Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Forner

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Journal for Immunotherapy of Cancer|October 1, 2021
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapyDavid J Pinato, Sam M Murray, Alejandro Forner, et al.
Gut|May 17, 2022
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directionsRocio I R Macias, Vincenzo Cardinale, Timothy J Kendall, et al.
Cancers|May 28, 2022
Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA RegistryLynn E Nooijen, Jesus M Banales, Marieke T de Boer, et al.
Journal of Hepatology|October 28, 2025
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 updateMaria Reig, Marco Sanduzzi-Zamparelli, Alejandro Forner, et al.
The Lancet Regional Health. Europe|March 17, 2025
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across EuropeLorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
The Lancet Regional Health. Europe|May 19, 2025
Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
Journal of Hepatology|December 2, 2021
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodulesMarco Sanduzzi-Zamparelli, Zoe Mariño, Sabela Lens, et al.
Medicina Clinica|January 19, 2021
Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETHMaría Reig, Alejandro Forner, Matías A Ávila, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 12, 2017
Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort studyFernando Agüero, Alejandro Forner, Andrés Valdivieso, et al.
Hepatology (Baltimore, Md.)|October 31, 2015
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinomaFernando Agüero, Alejandro Forner, Christian Manzardo, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Journal for Immunotherapy of Cancer|October 1, 2021
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapyDavid J Pinato, Sam M Murray, Alejandro Forner, et al.
Gut|May 17, 2022
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directionsRocio I R Macias, Vincenzo Cardinale, Timothy J Kendall, et al.
Cancers|May 28, 2022
Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA RegistryLynn E Nooijen, Jesus M Banales, Marieke T de Boer, et al.
Journal of Hepatology|October 28, 2025
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 updateMaria Reig, Marco Sanduzzi-Zamparelli, Alejandro Forner, et al.
The Lancet Regional Health. Europe|March 17, 2025
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across EuropeLorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
The Lancet Regional Health. Europe|May 19, 2025
Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
Journal of Hepatology|December 2, 2021
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodulesMarco Sanduzzi-Zamparelli, Zoe Mariño, Sabela Lens, et al.
Medicina Clinica|January 19, 2021
Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETHMaría Reig, Alejandro Forner, Matías A Ávila, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 12, 2017
Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort studyFernando Agüero, Alejandro Forner, Andrés Valdivieso, et al.
Hepatology (Baltimore, Md.)|October 31, 2015
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinomaFernando Agüero, Alejandro Forner, Christian Manzardo, et al.
Pageof 11